Current evaluation of drugs for treating arthritis.
D000082:Acetaminophen / Q000627:therapeutic use; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use; D002738:Chloroquine / Q000627:therapeutic use; D003061:Codeine / Q000009:adverse effects; D003348:Cortisone / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D011431:Dextropropoxyphene / Q000627:therapeutic use; D006046:Gold / Q000009:adverse effects / Q000627:therapeutic use; D006073:Gout / Q000188:drug therapy; D006801:Humans; D007213:Indomethacin / Q000008:administration & dosage; D008528:Mefenamic Acid / Q000627:therapeutic use; D010423:Pentazocine / Q000627:therapeutic use; D010653:Phenylbutazone / Q000008:administration & dosage; D012459:Salicylates / Q000008:administration & dosage; D013167:Spondylitis, Ankylosing / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D012459:Salicylates; D000082:Acetaminophen; D008528:Mefenamic Acid; D006046:Gold; D002738:Chloroquine; D003520:Cyclophosphamide; D010653:Phenylbutazone; D001241:Aspirin; D010423:Pentazocine; D011431:Dextropropoxyphene; D003061:Codeine; D003348:Cortisone; D007213:Indomethacin